Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 08:03:02 11/09/26 pm AEST			5-day change	1st Jan Change
2,837.20 ^INR	-0.13%		-3.34%	+14.82%

03/08	GSK India first-quarter profit rises on steady vaccine demand	RE
03/08	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	480,639	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	24.25%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	480,639	480,639
Change	-	-18.99%	58.51%	48.08%	-20.64%	24.25%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	41.3x	35.8x
PBR	10.6x	12.9x	18.5x	25x	17.1x	18.1x	15.2x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.3x	2.4x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	11.3x	10.2x
EV / Revenue	0x	0x	0x	0x	0x	11.3x	10.2x
EV / EBITDA	0x	0x	0x	0x	0x	32.4x	28.2x
EV / EBIT	0x	0x	0x	0x	0x	32.7x	28.1x
EV / FCF	0x	0x	0x	0x	0x	40x	36.5x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.5%	2.74%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.04%	1.04%
EPS ²	100	36.05	34.83	54.76	61.15	68.78	79.18
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	42.9%	37.3%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	42,568	47,241
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,836	17,070
EBIT ¹	7,592	7,385	8,390	11,106	12,428	14,698	17,112
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,654	13,418
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,837.20	2,837.20
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	16/5/22	17/5/23	17/5/24	13/5/25	13/5/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	41.31x	-	-	1.04%	5.03B
ELI LILLY AND COMPANY	31.96x	11.62x	23.56x	0.62%	1,001B
JOHNSON & JOHNSON	29.63x	-	-	2.02%	642B
ABBVIE INC.	32.65x	7.56x	15.72x	2.69%	451B
ROCHE HOLDING AG	18.78x	4.58x	11.35x	2.9%	340B
NOVARTIS AG	19.52x	5.11x	12.66x	3.19%	263B
ASTRAZENECA PLC	20.44x	4.2x	12.01x	2.1%	247B
AMGEN INC.	24.19x	6.38x	11.35x	2.64%	207B
NOVO NORDISK A/S	12.74x	4.63x	9.67x	3.94%	197B
GILEAD SCIENCES, INC.	-43.8x	6.4x	24.98x	2.27%	180B
Average	18.74x	6.31x	15.16x	2.34%	353.14B
Weighted average by Cap.	23.26x	7.75x	17.18x	2.04%